Replies to post #311948 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

A failed medical trial, especially in the case of NWBO since it's their only trial, will force NWBO a major deduction of its financial asset. They have spent near $ 1 billion into the trials can be considered as sunk cost. It doesn't matter its only partially om their balance sheet.

Only what is on the books today can be impaired. And in that case nothing shows. You can not take the loss as you spend the cash then take it again by writing it off.

Often substantial R&D assets are on books, particularly for BP.

For NWBO, there is no inventory, no intangibles no amortized R&D. And the expenses towards manufacturing assets have no need to be written off as they will be used for manufacturing just as Cognate does. I see nothing that would need to be written down.

[JerryCampbell]

@Anders,

You can't write down an asset that does not exist. Let's look at the last 10-Q.

Cash 5,955
Prepaids 2,262

propery, plant, equipment 157
construction in progress 1,541
right of way 4,236
other assets 755

That's all the assets on the balance sheet. Cash and prepaids are real money, so can't write those down. Right of way is a lease issue, so not specific to the trial.

So they might be able to write down PPE, Construction in Progress, and whatever is in Other Assets. That's a bit over $2 million.

As far as the $1B you mention as spent, that is already shown on the Balance Sheet as $895 million Accumulated Defecit. It has already been expensed, so there is nothing to write off.

[MI Dendream]

And Anders drops the mic...

[Astavakra]

'nuf sed